Literature DB >> 22081993

Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agents.

Mariela Bollini1, Robert A Domaoal, Vinay V Thakur, Ricardo Gallardo-Macias, Krasimir A Spasov, Karen S Anderson, William L Jorgensen.   

Abstract

A 5-μM docking hit has been optimized to an extraordinarily potent (55 pM) non-nucleoside inhibitor of HIV reverse transcriptase. Use of free energy perturbation (FEP) calculations to predict relative free energies of binding aided the optimizations by identifying optimal substitution patterns for phenyl rings and a linker. The most potent resultant catechol diethers feature terminal uracil and cyanovinylphenyl groups. A halogen bond with Pro95 likely contributes to the extreme potency of compound 42. In addition, several examples are provided illustrating failures of attempted grafting of a substructure from a very active compound onto a seemingly related scaffold to improve its activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081993      PMCID: PMC3258498          DOI: 10.1021/jm201134m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  36 in total

1.  BACTERIOSTATS. VII. SUBSTITUTED BENZYLPHENOLS.

Authors:  A F MCKAY; H A BAKER; R GAUDRY; D L GARMAISE; R J RANZ
Journal:  J Med Chem       Date:  1963-11       Impact factor: 7.446

2.  BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease.

Authors:  Albert C Pierce; Govinda Rao; Guy W Bemis
Journal:  J Med Chem       Date:  2004-05-20       Impact factor: 7.446

Review 3.  Molecular modeling of organic and biomolecular systems using BOSS and MCPRO.

Authors:  William L Jorgensen; Julian Tirado-Rives
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

Review 4.  The search for potent, small molecule NNRTIs: A review.

Authors:  Dhaval G Prajapati; R Ramajayam; Mange Ram Yadav; Rajani Giridhar
Journal:  Bioorg Med Chem       Date:  2009-07-03       Impact factor: 3.641

5.  Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.

Authors:  A L Hopkins; J Ren; R M Esnouf; B E Willcox; E Y Jones; C Ross; T Miyasaka; R T Walker; H Tanaka; D K Stammers; D I Stuart
Journal:  J Med Chem       Date:  1996-04-12       Impact factor: 7.446

6.  Methoxyacetyl as a protecting group in ribonucleoside chemistry.

Authors:  C B Reese; J C Stewart
Journal:  Tetrahedron Lett       Date:  1968-08       Impact factor: 2.415

Review 7.  In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine).

Authors:  Paul A J Janssen; Paul J Lewi; Eddy Arnold; Frits Daeyaert; Marc de Jonge; Jan Heeres; Luc Koymans; Maarten Vinkers; Jérôme Guillemont; Elisabeth Pasquier; Mike Kukla; Don Ludovici; Koen Andries; Marie-Pierre de Béthune; Rudi Pauwels; Kalyan Das; Art D Clark; Yulia Volovik Frenkel; Stephen H Hughes; Bart Medaer; Fons De Knaep; Hilde Bohets; Fred De Clerck; Ann Lampo; Peter Williams; Paul Stoffels
Journal:  J Med Chem       Date:  2005-03-24       Impact factor: 7.446

Review 8.  Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents.

Authors:  Jessica Adams; Nimish Patel; Nancy Mankaryous; Mariam Tadros; Christopher D Miller
Journal:  Ann Pharmacother       Date:  2009-12-08       Impact factor: 3.154

9.  Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.

Authors:  T S Lin; M Z Luo; M C Liu; S B Pai; G E Dutschman; Y C Cheng
Journal:  Biochem Pharmacol       Date:  1994-01-20       Impact factor: 5.858

10.  3-iodo-4-phenoxypyridinones (IOPY's), a new family of highly potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Authors:  Abdellah Benjahad; Jérôme Guillemont; Koen Andries; Chi Hung Nguyen; David S Grierson
Journal:  Bioorg Med Chem Lett       Date:  2003-12-15       Impact factor: 2.823

View more
  45 in total

1.  Double Variational Binding--(SMILES) Conformational Analysis by Docking Mechanisms for Anti-HIV Pyrimidine Ligands.

Authors:  Mihai V Putz; Nicoleta A Dudaș; Adriana Isvoran
Journal:  Int J Mol Sci       Date:  2015-08-18       Impact factor: 5.923

Review 2.  Metal Ion Modeling Using Classical Mechanics.

Authors:  Pengfei Li; Kenneth M Merz
Journal:  Chem Rev       Date:  2017-01-03       Impact factor: 60.622

3.  Predicting Binding Free Energies in a Large Combinatorial Chemical Space Using Multisite λ Dynamics.

Authors:  Jonah Z Vilseck; Kira A Armacost; Ryan L Hayes; Garrett B Goh; Charles L Brooks
Journal:  J Phys Chem Lett       Date:  2018-06-06       Impact factor: 6.475

4.  Drug-protein interactions: Mechanisms of potency.

Authors:  Christopher M Cheatum
Journal:  Nat Chem       Date:  2013-03       Impact factor: 24.427

5.  Discovery of dimeric inhibitors by extension into the entrance channel of HIV-1 reverse transcriptase.

Authors:  Anil R Ekkati; Mariela Bollini; Robert A Domaoal; Krasimir A Spasov; Karen S Anderson; William L Jorgensen
Journal:  Bioorg Med Chem Lett       Date:  2012-01-05       Impact factor: 2.823

6.  Potent Inhibitors Active against HIV Reverse Transcriptase with K101P, a Mutation Conferring Rilpivirine Resistance.

Authors:  William T Gray; Kathleen M Frey; Sarah B Laskey; Andrea C Mislak; Krasimir A Spasov; Won-Gil Lee; Mariela Bollini; Robert F Siliciano; William L Jorgensen; Karen S Anderson
Journal:  ACS Med Chem Lett       Date:  2015-08-31       Impact factor: 4.345

Review 7.  Anti-HIV drug development through computational methods.

Authors:  Wan-Gang Gu; Xuan Zhang; Jun-Fa Yuan
Journal:  AAPS J       Date:  2014-04-24       Impact factor: 4.009

8.  Computer-aided discovery of anti-HIV agents.

Authors:  William L Jorgensen
Journal:  Bioorg Med Chem       Date:  2016-07-21       Impact factor: 3.641

9.  Structure-based evaluation of C5 derivatives in the catechol diether series targeting HIV-1 reverse transcriptase.

Authors:  Kathleen M Frey; William T Gray; Krasimir A Spasov; Mariela Bollini; Ricardo Gallardo-Macias; William L Jorgensen; Karen S Anderson
Journal:  Chem Biol Drug Des       Date:  2014-03-14       Impact factor: 2.817

10.  Treatment of Halogen Bonding in the OPLS-AA Force Field; Application to Potent Anti-HIV Agents.

Authors:  William L Jorgensen; Patric Schyman
Journal:  J Chem Theory Comput       Date:  2012-04-03       Impact factor: 6.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.